USA Digital Companion Diagnostics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Digital Companion Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Digital Companion Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Digital Companion Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • GE Healthcare (UK)

    • Agilent Technologies (US)

    • Agendia (Angola)

    • Advanced Cell Diagnostics (US)

    • Qiagen (Germany)

    • Thermo Fisher Scientific (US)

    • Roche Holdings (Switzerland)

    • Genomic Health (US)

    • Danaher (US)

    • Life Technologies (US)

    • Abbott Laboratories (US)

    • Myriad Genetics (US)

    • Applied Proteomics (US)

    By Type:

    • Polymerase Chain Reaction (PCR)

    • Immunohistochemistry (IHC)

    • In Situ Hybridization (ISH)

    • Next Generation Sequencing (NGS)

    By End-User:

    • Hospitals

    • Pharmaceutical Companies

    • Laboratories

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Digital Companion Diagnostics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Digital Companion Diagnostics Market Size and Growth Rate of Polymerase Chain Reaction (PCR) from 2016 to 2027

      • 1.3.2 USA Digital Companion Diagnostics Market Size and Growth Rate of Immunohistochemistry (IHC) from 2016 to 2027

      • 1.3.3 USA Digital Companion Diagnostics Market Size and Growth Rate of In Situ Hybridization (ISH) from 2016 to 2027

      • 1.3.4 USA Digital Companion Diagnostics Market Size and Growth Rate of Next Generation Sequencing (NGS) from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Digital Companion Diagnostics Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.2 USA Digital Companion Diagnostics Market Size and Growth Rate of Pharmaceutical Companies from 2016 to 2027

      • 1.4.3 USA Digital Companion Diagnostics Market Size and Growth Rate of Laboratories from 2016 to 2027

      • 1.4.4 USA Digital Companion Diagnostics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Digital Companion Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Digital Companion Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Digital Companion Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Digital Companion Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Digital Companion Diagnostics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Digital Companion Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Polymerase Chain Reaction (PCR)

      • 3.4.2 Market Size and Growth Rate of Immunohistochemistry (IHC)

      • 3.4.3 Market Size and Growth Rate of In Situ Hybridization (ISH)

      • 3.4.4 Market Size and Growth Rate of Next Generation Sequencing (NGS)

    4 Segmentation of Digital Companion Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Digital Companion Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Digital Companion Diagnostics in Hospitals

      • 4.4.2 Market Size and Growth Rate of Digital Companion Diagnostics in Pharmaceutical Companies

      • 4.4.3 Market Size and Growth Rate of Digital Companion Diagnostics in Laboratories

      • 4.4.4 Market Size and Growth Rate of Digital Companion Diagnostics in Other

    5 Market Analysis by Regions

    • 5.1 USA Digital Companion Diagnostics Production Analysis by Regions

    • 5.2 USA Digital Companion Diagnostics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Digital Companion Diagnostics Landscape Analysis

    • 6.1 West USA Digital Companion Diagnostics Landscape Analysis by Major Types

    • 6.2 West USA Digital Companion Diagnostics Landscape Analysis by Major End-Users

    7 South USA Digital Companion Diagnostics Landscape Analysis

    • 7.1 South USA Digital Companion Diagnostics Landscape Analysis by Major Types

    • 7.2 South USA Digital Companion Diagnostics Landscape Analysis by Major End-Users

    8 Middle West USA Digital Companion Diagnostics Landscape Analysis

    • 8.1 Middle West USA Digital Companion Diagnostics Landscape Analysis by Major Types

    • 8.2 Middle West USA Digital Companion Diagnostics Landscape Analysis by Major End-Users

    9 Northeast USA Digital Companion Diagnostics Landscape Analysis

    • 9.1 Northeast USA Digital Companion Diagnostics Landscape Analysis by Major Types

    • 9.2 Northeast USA Digital Companion Diagnostics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 GE Healthcare (UK)

        • 10.1.1 GE Healthcare (UK) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Agilent Technologies (US)

        • 10.2.1 Agilent Technologies (US) Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Agendia (Angola)

        • 10.3.1 Agendia (Angola) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Advanced Cell Diagnostics (US)

        • 10.4.1 Advanced Cell Diagnostics (US) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Qiagen (Germany)

        • 10.5.1 Qiagen (Germany) Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Thermo Fisher Scientific (US)

        • 10.6.1 Thermo Fisher Scientific (US) Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Roche Holdings (Switzerland)

        • 10.7.1 Roche Holdings (Switzerland) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Genomic Health (US)

        • 10.8.1 Genomic Health (US) Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Danaher (US)

        • 10.9.1 Danaher (US) Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Life Technologies (US)

        • 10.10.1 Life Technologies (US) Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Abbott Laboratories (US)

        • 10.11.1 Abbott Laboratories (US) Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Myriad Genetics (US)

        • 10.12.1 Myriad Genetics (US) Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Applied Proteomics (US)

        • 10.13.1 Applied Proteomics (US) Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Digital Companion Diagnostics Market Size and Growth Rate of Polymerase Chain Reaction (PCR) from 2016 to 2027

    • Figure USA Digital Companion Diagnostics Market Size and Growth Rate of Immunohistochemistry (IHC) from 2016 to 2027

    • Figure USA Digital Companion Diagnostics Market Size and Growth Rate of In Situ Hybridization (ISH) from 2016 to 2027

    • Figure USA Digital Companion Diagnostics Market Size and Growth Rate of Next Generation Sequencing (NGS) from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Digital Companion Diagnostics Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Digital Companion Diagnostics Market Size and Growth Rate of Pharmaceutical Companies from 2016 to 2027

    • Figure USA Digital Companion Diagnostics Market Size and Growth Rate of Laboratories from 2016 to 2027

    • Figure USA Digital Companion Diagnostics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Digital Companion Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Digital Companion Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Digital Companion Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Digital Companion Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Digital Companion Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Digital Companion Diagnostics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Digital Companion Diagnostics by Different Types from 2016 to 2027

    • Table Consumption Share of Digital Companion Diagnostics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Polymerase Chain Reaction (PCR)

    • Figure Market Size and Growth Rate of Immunohistochemistry (IHC)

    • Figure Market Size and Growth Rate of In Situ Hybridization (ISH)

    • Figure Market Size and Growth Rate of Next Generation Sequencing (NGS)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Digital Companion Diagnostics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Digital Companion Diagnostics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Pharmaceutical Companies

    • Figure Market Size and Growth Rate of Laboratories

    • Figure Market Size and Growth Rate of Other

    • Table USA Digital Companion Diagnostics Production by Regions

    • Table USA Digital Companion Diagnostics Production Share by Regions

    • Figure USA Digital Companion Diagnostics Production Share by Regions in 2016

    • Figure USA Digital Companion Diagnostics Production Share by Regions in 2021

    • Figure USA Digital Companion Diagnostics Production Share by Regions in 2027

    • Table USA Digital Companion Diagnostics Consumption by Regions

    • Table USA Digital Companion Diagnostics Consumption Share by Regions

    • Figure USA Digital Companion Diagnostics Consumption Share by Regions in 2016

    • Figure USA Digital Companion Diagnostics Consumption Share by Regions in 2021

    • Figure USA Digital Companion Diagnostics Consumption Share by Regions in 2027

    • Table West USA Digital Companion Diagnostics Consumption by Types from 2016 to 2027

    • Table West USA Digital Companion Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure West USA Digital Companion Diagnostics Consumption Share by Types in 2016

    • Figure West USA Digital Companion Diagnostics Consumption Share by Types in 2021

    • Figure West USA Digital Companion Diagnostics Consumption Share by Types in 2027

    • Table West USA Digital Companion Diagnostics Consumption by End-Users from 2016 to 2027

    • Table West USA Digital Companion Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Digital Companion Diagnostics Consumption Share by End-Users in 2016

    • Figure West USA Digital Companion Diagnostics Consumption Share by End-Users in 2021

    • Figure West USA Digital Companion Diagnostics Consumption Share by End-Users in 2027

    • Table South USA Digital Companion Diagnostics Consumption by Types from 2016 to 2027

    • Table South USA Digital Companion Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure South USA Digital Companion Diagnostics Consumption Share by Types in 2016

    • Figure South USA Digital Companion Diagnostics Consumption Share by Types in 2021

    • Figure South USA Digital Companion Diagnostics Consumption Share by Types in 2027

    • Table South USA Digital Companion Diagnostics Consumption by End-Users from 2016 to 2027

    • Table South USA Digital Companion Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Digital Companion Diagnostics Consumption Share by End-Users in 2016

    • Figure South USA Digital Companion Diagnostics Consumption Share by End-Users in 2021

    • Figure South USA Digital Companion Diagnostics Consumption Share by End-Users in 2027

    • Table Middle West USA Digital Companion Diagnostics Consumption by Types from 2016 to 2027

    • Table Middle West USA Digital Companion Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Digital Companion Diagnostics Consumption Share by Types in 2016

    • Figure Middle West USA Digital Companion Diagnostics Consumption Share by Types in 2021

    • Figure Middle West USA Digital Companion Diagnostics Consumption Share by Types in 2027

    • Table Middle West USA Digital Companion Diagnostics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Digital Companion Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Digital Companion Diagnostics Consumption Share by End-Users in 2016

    • Figure Middle West USA Digital Companion Diagnostics Consumption Share by End-Users in 2021

    • Figure Middle West USA Digital Companion Diagnostics Consumption Share by End-Users in 2027

    • Table Northeast USA Digital Companion Diagnostics Consumption by Types from 2016 to 2027

    • Table Northeast USA Digital Companion Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Digital Companion Diagnostics Consumption Share by Types in 2016

    • Figure Northeast USA Digital Companion Diagnostics Consumption Share by Types in 2021

    • Figure Northeast USA Digital Companion Diagnostics Consumption Share by Types in 2027

    • Table Northeast USA Digital Companion Diagnostics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Digital Companion Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Digital Companion Diagnostics Consumption Share by End-Users in 2016

    • Figure Northeast USA Digital Companion Diagnostics Consumption Share by End-Users in 2021

    • Figure Northeast USA Digital Companion Diagnostics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of GE Healthcare (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare (UK)

    • Figure Sales and Growth Rate Analysis of GE Healthcare (UK)

    • Figure Revenue and Market Share Analysis of GE Healthcare (UK)

    • Table Product and Service Introduction of GE Healthcare (UK)

    • Table Company Profile and Development Status of Agilent Technologies (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies (US)

    • Figure Sales and Growth Rate Analysis of Agilent Technologies (US)

    • Figure Revenue and Market Share Analysis of Agilent Technologies (US)

    • Table Product and Service Introduction of Agilent Technologies (US)

    • Table Company Profile and Development Status of Agendia (Angola)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agendia (Angola)

    • Figure Sales and Growth Rate Analysis of Agendia (Angola)

    • Figure Revenue and Market Share Analysis of Agendia (Angola)

    • Table Product and Service Introduction of Agendia (Angola)

    • Table Company Profile and Development Status of Advanced Cell Diagnostics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Cell Diagnostics (US)

    • Figure Sales and Growth Rate Analysis of Advanced Cell Diagnostics (US)

    • Figure Revenue and Market Share Analysis of Advanced Cell Diagnostics (US)

    • Table Product and Service Introduction of Advanced Cell Diagnostics (US)

    • Table Company Profile and Development Status of Qiagen (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen (Germany)

    • Figure Sales and Growth Rate Analysis of Qiagen (Germany)

    • Figure Revenue and Market Share Analysis of Qiagen (Germany)

    • Table Product and Service Introduction of Qiagen (Germany)

    • Table Company Profile and Development Status of Thermo Fisher Scientific (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific (US)

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific (US)

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific (US)

    • Table Product and Service Introduction of Thermo Fisher Scientific (US)

    • Table Company Profile and Development Status of Roche Holdings (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Holdings (Switzerland)

    • Figure Sales and Growth Rate Analysis of Roche Holdings (Switzerland)

    • Figure Revenue and Market Share Analysis of Roche Holdings (Switzerland)

    • Table Product and Service Introduction of Roche Holdings (Switzerland)

    • Table Company Profile and Development Status of Genomic Health (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health (US)

    • Figure Sales and Growth Rate Analysis of Genomic Health (US)

    • Figure Revenue and Market Share Analysis of Genomic Health (US)

    • Table Product and Service Introduction of Genomic Health (US)

    • Table Company Profile and Development Status of Danaher (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher (US)

    • Figure Sales and Growth Rate Analysis of Danaher (US)

    • Figure Revenue and Market Share Analysis of Danaher (US)

    • Table Product and Service Introduction of Danaher (US)

    • Table Company Profile and Development Status of Life Technologies (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Life Technologies (US)

    • Figure Sales and Growth Rate Analysis of Life Technologies (US)

    • Figure Revenue and Market Share Analysis of Life Technologies (US)

    • Table Product and Service Introduction of Life Technologies (US)

    • Table Company Profile and Development Status of Abbott Laboratories (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories (US)

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories (US)

    • Figure Revenue and Market Share Analysis of Abbott Laboratories (US)

    • Table Product and Service Introduction of Abbott Laboratories (US)

    • Table Company Profile and Development Status of Myriad Genetics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics (US)

    • Figure Sales and Growth Rate Analysis of Myriad Genetics (US)

    • Figure Revenue and Market Share Analysis of Myriad Genetics (US)

    • Table Product and Service Introduction of Myriad Genetics (US)

    • Table Company Profile and Development Status of Applied Proteomics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Applied Proteomics (US)

    • Figure Sales and Growth Rate Analysis of Applied Proteomics (US)

    • Figure Revenue and Market Share Analysis of Applied Proteomics (US)

    • Table Product and Service Introduction of Applied Proteomics (US)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.